跳至主要内容
临床试验/EUCTR2004-001098-25-ES
EUCTR2004-001098-25-ES进行中(未招募)1 期

Acetylcisteine (NAC) effect on the inmunologycal system

Zambon SA0 个研究点目标入组 40 人开始时间: 2012年4月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Zambon SA
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Postmenopausal women in good health more than 50 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Women with a clinical condition or relevant analytical alterations
  • -Severe general condition
  • -Lymphacyte Proliferation values outside of the normal range for the age
  • -Immune diseases
  • -Dementia or cognitive alteration
  • -Chronic respiratory condition
  • -Arterial hypertension
  • -Life expectancy < 1 year
  • -Low compliance level
  • -Continuous intake on N-acetylcysteine or vitamins or antioxidants in the previous six months

研究者

发起方
Zambon SA

相似试验

Effect of the N-acetylcysteine in the inmunologycal... | 临床试验